106 related articles for article (PubMed ID: 8977043)
1. Transrearrangements as biomarkers for risk of lymphoid malignancy.
Kirsch IR; Lista F
Cancer Surv; 1996; 28():311-27. PubMed ID: 8977043
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-specific genomic instability and risk of lymphoid malignancy.
Kirsch IR; Lista F
Semin Immunol; 1997 Jun; 9(3):207-15. PubMed ID: 9200332
[TBL] [Abstract][Full Text] [Related]
3. The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a severe combined immune deficiency (SCID) murine model.
Lista F; Bertness V; Guidos CJ; Danska JS; Kirsch IR
Cancer Res; 1997 Oct; 57(19):4408-13. PubMed ID: 9331104
[TBL] [Abstract][Full Text] [Related]
4. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
5. VDJ recombination.
Alt FW; Oltz EM; Young F; Gorman J; Taccioli G; Chen J
Immunol Today; 1992 Aug; 13(8):306-14. PubMed ID: 1510813
[TBL] [Abstract][Full Text] [Related]
6. Recombinase deficiency in mouse and man.
Schwarz K; Hansen-Hagge TE; Bartram CR
Immunodeficiency; 1993; 4(1-4):249-52. PubMed ID: 8167711
[No Abstract] [Full Text] [Related]
7. Accessibility control of V(D)J recombination.
Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.
Tycko B; Sklar J
Cancer Cells; 1990 Jan; 2(1):1-8. PubMed ID: 2201335
[TBL] [Abstract][Full Text] [Related]
9. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
10. Accessibility and the developmental regulation of V(D)J recombination.
Schlissel MS; Stanhope-Baker P
Semin Immunol; 1997 Jun; 9(3):161-70. PubMed ID: 9200327
[TBL] [Abstract][Full Text] [Related]
11. An ionizing radiation-sensitive CHO mutant cell line: irs-20. IV. Genetic complementation, V(D)J recombination and the scid phenotype.
Lin JY; Mühlmann-Diaz MC; Stackhouse MA; Robinson JF; Taccioli GE; Chen DJ; Bedford JS
Radiat Res; 1997 Feb; 147(2):166-71. PubMed ID: 9008208
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of aberrant interlocus T-cell receptor rearrangements in mouse thymocytes and the effect of the herbicide 2,4-dichlorophenoxyacetic acid.
Knapp GW; Setzer RW; Fuscoe JC
Environ Mol Mutagen; 2003; 42(1):37-43. PubMed ID: 12874811
[TBL] [Abstract][Full Text] [Related]
13. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
Swanson PC
Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
[TBL] [Abstract][Full Text] [Related]
14. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining.
Soulas-Sprauel P; Rivera-Munoz P; Malivert L; Le Guyader G; Abramowski V; Revy P; de Villartay JP
Oncogene; 2007 Dec; 26(56):7780-91. PubMed ID: 18066091
[TBL] [Abstract][Full Text] [Related]
15. V(D)J recombination and the evolution of the adaptive immune system.
Market E; Papavasiliou FN
PLoS Biol; 2003 Oct; 1(1):E16. PubMed ID: 14551913
[TBL] [Abstract][Full Text] [Related]
16. Who's the dealer? What controls gene shuffling in the immune system?
Rennie J
Sci Am; 1990 Mar; 262(3):30, 32. PubMed ID: 2315667
[No Abstract] [Full Text] [Related]
17. Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion.
Breit TM; Verschuren MC; Wolvers-Tettero IL; Van Gastel-Mol EJ; Hählen K; van Dongen JJ
J Immunol; 1997 Nov; 159(9):4341-9. PubMed ID: 9379030
[TBL] [Abstract][Full Text] [Related]
18. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.
Sprangers M; Feldhahn N; Liedtke S; Jumaa H; Siebert R; Müschen M
Oncogene; 2006 Aug; 25(37):5180-6. PubMed ID: 16636677
[TBL] [Abstract][Full Text] [Related]
19. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
20. The mechanism and regulation of chromosomal V(D)J recombination.
Bassing CH; Swat W; Alt FW
Cell; 2002 Apr; 109 Suppl():S45-55. PubMed ID: 11983152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
